Lilly to Acquire Morphic to Improve Outcomes for Patients with Inflammatory Bowel Disease
Roughly 67% of Morphic Holding's investor base is looking to short. The analysis of current outlook of investing in Morphic Holding suggests that many traders are alarmed regarding Morphic Holding's prospects. The current market sentiment, together with Morphic Holding's historical and current headlines, can help investors time the market. In addition, many technical investors use Morphic Holding stock news signals to limit their universe of possible portfolio assets.
Morphic |
Eli Lilly and Company and Morphic Holding, Inc. today announced a definitive agreement for Lilly to acquire Morphic, a biopharmaceutical company developing oral integrin therapies for treatment of serious chronic diseases.
Read at finance.yahoo.com
Morphic Holding Fundamental Analysis
We analyze Morphic Holding's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Morphic Holding using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Morphic Holding based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash And Equivalents
Cash And Equivalents Comparative Analysis
Morphic Holding is currently under evaluation in cash and equivalents category among its peers. Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Morphic Holding Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Morphic Holding stock to make a market-neutral strategy. Peer analysis of Morphic Holding could also be used in its relative valuation, which is a method of valuing Morphic Holding by comparing valuation metrics with similar companies.
Peers
Morphic Holding Related Equities
TERN | Terns Pharmaceuticals | 2.12 | ||||
PTGX | Protagonist Therapeutics | 1.86 | ||||
INZY | Inozyme Pharma | 1.68 | ||||
MDGL | Madrigal Pharmaceuticals | 0.73 | ||||
ACLX | Arcellx | 0.46 | ||||
RVMD | Revolution Medicines | 0.18 | ||||
AKRO | Akero Therapeutics | 0.45 | ||||
VKTX | Viking Therapeutics | 1.75 | ||||
ETNB | 89bio | 1.91 | ||||
STOK | Stoke Therapeutics | 1.95 | ||||
PCVX | Vaxcyte | 3.60 | ||||
RNA | Avidity Biosciences | 3.73 | ||||
PLRX | Pliant Therapeutics | 3.97 | ||||
IMCR | Immunocore Holdings | 4.62 | ||||
VTYX | Ventyx Biosciences | 6.15 |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Consideration for investing in Morphic Stock
If you are still planning to invest in Morphic Holding check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Morphic Holding's history and understand the potential risks before investing.
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |